Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

P Morgan, PH Van Der Graaf, J Arrowsmith… - Drug discovery today, 2012 - Elsevier
In an effort to uncover systematic learnings that can be applied to improve compound
survival, an analysis was performed on data from Phase II decisions for 44 programs at …

[HTML][HTML] Methods of model reduction for large-scale biological systems: a survey of current methods and trends

TJ Snowden, PH van der Graaf, MJ Tindall - Bulletin of mathematical …, 2017 - Springer
Complex models of biochemical reaction systems have become increasingly common in the
systems biology literature. The complexity of such models can present a number of …

Towards a mechanism-based analysis of pharmacodynamic drug–drug interactions in vivo

DM Jonker, SAG Visser, PH Van Der Graaf… - Pharmacology & …, 2005 - Elsevier
The combination of drugs is a common practice for enhancing the efficiency of drug
treatment, but selection of the optimal combination and the optimal doses remains a matter …

[PDF][PDF] Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms

PK Sorger, SRB Allerheiligen… - An NIH white …, 2011 - customsitesmedia.usc.edu
Background: This white paper arises from two workshops held at the NIH in 2008 and late
2010 with participation from academia, industry and government (http://meetings. nigms. nih …

Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development

PH Van der Graaf, N Benson - Pharmaceutical research, 2011 - Springer
Mechanistic PKPD models are now advocated not only by academic and industrial
researchers, but also by regulators. A recent development in this area is based on the …

Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders

T Pattij, TR De Jong, A Uitterdijk… - European Journal of …, 2005 - Wiley Online Library
In addition to investigating sexual function in rats that display normal ejaculatory behaviour,
studying rats that are either 'hyposexual'or 'hypersexual'may provide important insights into …

The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics

BM Agoram, SW Martin, PH Van der Graaf - Drug discovery today, 2007 - Elsevier
Lack of predictability of clinical efficacy and safety is an important problem facing
pharmaceutical research today. Translational PK–PD has the ability to integrate data …

Drug disposition in obesity: toward evidence-based dosing

CAJ Knibbe, MJE Brill, A van Rongen… - Annual review of …, 2015 - annualreviews.org
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …

In vivo target residence time and kinetic selectivity: the association rate constant as determinant

WEA de Witte, M Danhof, PH van der Graaf… - Trends in …, 2016 - cell.com
It is generally accepted that, in conjunction with pharmacokinetics, the first-order rate
constant of target dissociation is a major determinant of the time course and duration of in …

[HTML][HTML] Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine

I Kohler, T Hankemeier, PH van der Graaf… - European journal of …, 2017 - Elsevier
Novel developments in biomarkers discovery are essential in modern health care, notably in
treatment individualization and precision medicine. Clinical metabolomics, which aims to …